Skip Nav Destination
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group
Issue Archive
January 13 2026
In Progress
Volume 10 Issue 1 | Blood Advances | American Society of Hematology
CLINICAL TRIALS AND OBSERVATIONS
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
Clinical Trials & Observations
Dimana Dimitrova,Elisabetta Xue,Mustafa A. Hyder,Hyoyoung Choo-Wosoba,Kamil Rechache,Francis A. Flomerfelt,Sanchita Das,Christi McKeown,Alison Cusmano,Ruby Sabina,Jennifer A. Kanakry,Christopher G. Kanakry
THROMBOSIS AND HEMOSTASIS
RESEARCH LETTER
Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia
Clinical Trials & Observations
Nicholas J. Short,Hagop Kantarjian,Nitin Jain,Tapan M. Kadia,Jayastu Senapati,Fadi G. Haddad,Manuel M. Maroun,Koji Sasaki,Lianchun Xiao,Xuelin Huang,Omer Karrar,Regina Abramova,Min Zhao,Rebecca Garris,Marina Konopleva,Farhad Ravandi,Elias Jabbour
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
Clinical Trials & Observations
Kelly E. Faulk,John A. Kairalla,Emily Hibbitts,Janel Long-Boyle,Meenakshi Devidas,Amanda August,Lia Gore,Elizabeth Raetz,Stephen P. Hunger,Mignon L. Loh,David T. Teachey,Patrick Brown,Erin H. Breese,Rishi S. Kotecha,Erin Guest
Lymphoid Neoplasia
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq
Yifan Yin,Shinya Rai,Aixiang Jiang,Alexander Xu,Luke O’Brien,Adèle Telenius,Jan Delabie,Lauren Chong,Stacy Hung,Akil Merchant,David W. Scott,Kerry J. Savage,Tomohiro Aoki,Christian Steidl
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group
Clinical Trials & Observations
Marion Aymard,Morgane Cheminant,Roch Houot,Anne Cuozzo,Elodie Gat,Catherine Thieblemont,Laure Ricard,Louise Roulin,Krimo Bouabdallah,Violaine Safar,Stéphanie Guidez,Amandine Fayard,Gabriel Brisou,Loic Ysebaert,Olivier Hermine,Benoît Tessoulin,Charles Herbaux,Steven Le Gouill,Clémentine Sarkozy
HEALTH SERVICES AND OUTCOMES
Accelerating novel therapies for sickle cell disease with RWE: ASH RC Data Hub as a strategically coordinated registry network
William A. Wood,Osman N. Yogurtcu,Emily Semmel,Kathleen Hewitt,Donna S. Neuberg,Lea B. Witkowsky,Ken Taymor,Santiago J. Molina,Jane S. Hankins,Alexis A. Thompson,Gregory Pappas
REVIEW ARTICLE
PLATELETS AND THROMBOPOIESIS
Plasma Cell Disorders
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection
Parvathi Sudha,Phillip Pham,Wen Niu,Enze Liu,Lin Wang,Gillian Truong,Cameron Ligocki,Ramzi Al-Azzawi,Malini Surapenini,Steven M. Bray,Francesco Vetrini,Magdalena Czader,Marwan K. Tayeh,Kelvin Lee,Rafat Abonour,Attaya Suvannasankha,Brian A. Walker
Advertisement intended for health care professionals
Advertisement intended for health care professionals







